ArticleTranslational andrology and urology2019
The docetaxel debate: impact of chemotherapy in high-risk non-metastatic prostate cancer.
Mark D HurwitzPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it